| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/01/2006 | CN1243567C Growth hormone secretagogues |
| 03/01/2006 | CN1243543C Bioimplant formulation |
| 03/01/2006 | CN1243536C Use of sphingomyelin for preparing compositions to increase the levels of skin and mucosal ceramides, and dermatological and cosmetic composition |
| 02/28/2006 | US7005814 Motor control apparatus having current supply phase correction |
| 02/28/2006 | US7005560 Transgenic plants expressing assembled secretory antibodies |
| 02/28/2006 | US7005512 Comprises cytoskeletal protein for use as tool in identification of modulators for diagnosis, prevention and treatment of cardiomyopathies |
| 02/28/2006 | US7005509 Pancreatic expressed chemokines, (PANEC-1); expression vectors, host cells, and diagnostic tests using probes for physiologic or pathologic compromise of the pancreas |
| 02/28/2006 | US7005502 mixtures of von Willebrand factor(vWF) proteins and hemostatic agents, used for prophylaxis of blood disorders; antihemophilic factors |
| 02/28/2006 | US7005500 Nucleotide sequence coding polypeptide for use in the diagnosis of of neoplastic disorders |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005424 Admininstering mixtures of anticarcinogenic agents and early genes for prophylaxis of cancer, tumors or metastasis; gene expression inhibitors |
| 02/28/2006 | US7005420 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 02/28/2006 | US7005419 Methods for identifying inhibitors of GADD45 polypeptide activity and inhibitors of such activity |
| 02/28/2006 | US7005418 Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction |
| 02/28/2006 | US7005417 Echinocandin derivatives, method for preparing same and use as antifungal agents |
| 02/28/2006 | US7005416 Synergistic; treating grampositive and gramnegative bacterial infections, kits |
| 02/28/2006 | US7005415 Wherein the DNA synthesis promoting activity of the heparin-binding protein is increased by the covalently bonded sugar chain which can be heparan sulfate; improved in vivo stabilities such as acid resistance and alkali resistance |
| 02/28/2006 | US7005414 Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof |
| 02/28/2006 | US7005413 Administering an interleukin-1 (IL-1) inhibitor, a Tumor Necrosis Factor (TNF)-alpha inhibitor such as etanercept, and an Osteoprotegerin (OPG) protein of given amino acid sequence; osteoporosis |
| 02/28/2006 | US7005411 Method for modulating nerve cell function |
| 02/28/2006 | US7005286 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2006 | US7005285 Human p21-activated kinase 5 polypeptide |
| 02/28/2006 | US7005279 Process for producing carbohydrates using β 1,3-N-acetyl-glucosaminyltransferase |
| 02/28/2006 | US7005277 Defective adenoviruses and corresponding complementation lines |
| 02/28/2006 | US7005262 Methods for detecting nucleic acids encoding human telomerase reverse transcriptase |
| 02/28/2006 | US7005141 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 02/28/2006 | US7005139 Drug delivery, pharmacology and cancer chemotherapy |
| 02/28/2006 | US7005128 Enzyme feed additive and animal feed including it |
| 02/28/2006 | US7005127 Mixed-cell gene therapy |
| 02/28/2006 | US7004945 Devices and methods for the restoration of a spinal disc |
| 02/28/2006 | CA2515158A1 Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease |
| 02/28/2006 | CA2251916C Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
| 02/25/2006 | CA2479163A1 Novel leptin antagonist |
| 02/23/2006 | WO2006020984A2 Cyclosporin formulations |
| 02/23/2006 | WO2006020930A2 Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues |
| 02/23/2006 | WO2006020891A2 Chemokine combinations to mobilize progenitor/stem cells |
| 02/23/2006 | WO2006020841A2 Apparatus and method for transdermal delivery of natriuretic peptides |
| 02/23/2006 | WO2006020727A2 Methods for treating cns disorders by administration of agents to the nasal cavity |
| 02/23/2006 | WO2006020684A2 Methods of regulating differentiation and treating of multiple myeloma |
| 02/23/2006 | WO2006020581A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 02/23/2006 | WO2006020580A2 Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same |
| 02/23/2006 | WO2006020470A2 Promotion of axonal regeneration |
| 02/23/2006 | WO2006020319A2 Methods and compositions for producing target cell reactive lymphocytes in a subject |
| 02/23/2006 | WO2006020208A2 Therapeutic composition whit a botulinum neurotoxin |
| 02/23/2006 | WO2006020145A2 Flt3 inhibitors for immune suppression |
| 02/23/2006 | WO2006020127A1 Medical device for delivering biologically active material |
| 02/23/2006 | WO2006019982A2 Pin1-modulating compounds and methods of use thereof |
| 02/23/2006 | WO2006019904A1 Netrin-related compositions and uses |
| 02/23/2006 | WO2006019894A2 Nebulized pharmaceutical compositions for the treatment of bronchial disorders |
| 02/23/2006 | WO2006018633A1 Use of gsk-3 inhibitors for the treatment of prostate cancer |
| 02/23/2006 | WO2006018632A2 Cell therapy with exo 1 |
| 02/23/2006 | WO2006018551A1 Novel peptide and pharmaceutical composition containing said peptide |
| 02/23/2006 | WO2006018418A2 Antiangiogenic peptides |
| 02/23/2006 | WO2006018204A1 Modified vitamin k dependent polypeptides |
| 02/23/2006 | WO2006018088A1 Use of a pde 5 inhibitor for treating and preventing hypopigmentary disorders |
| 02/23/2006 | WO2006018024A2 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists |
| 02/23/2006 | WO2005123761A8 GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION |
| 02/23/2006 | WO2005123107A3 Immune response suppressor and treatment of multiple sclerosis |
| 02/23/2006 | WO2005116235A9 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment |
| 02/23/2006 | WO2005111069A3 Morphogenic proteins and stimulatory factors in gene therapy |
| 02/23/2006 | WO2005105843A3 Hiv protease inhibitors |
| 02/23/2006 | WO2005097176A3 Modulating oxalate transport |
| 02/23/2006 | WO2005092362A3 Pharmaceutical combined preparation containing a therapeutic protein |
| 02/23/2006 | WO2005074903A3 Sulfhydryl protected glutathione prodrug |
| 02/23/2006 | WO2005059546A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) |
| 02/23/2006 | WO2005057222A3 Use of t-cadherin as a target |
| 02/23/2006 | WO2005053618A3 Synthetic hla binding peptide analogues and uses thereof |
| 02/23/2006 | WO2005049792A3 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency |
| 02/23/2006 | WO2005045040A3 RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID /siNA) |
| 02/23/2006 | WO2005028497A3 Receptor binding peptides derived from the sars s protein |
| 02/23/2006 | WO2005016257A3 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/23/2006 | WO2004108885A3 Fc chimeric proteins with anti-hiv drugs |
| 02/23/2006 | WO2004071458A3 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 02/23/2006 | WO2004043406A3 ENGINEERED RNAi ADENOVIRUS SILENCING EXPRESSION (ERASE) OF DNA REPAIR PROTEINS |
| 02/23/2006 | WO2004043383A3 A new target for angiogenesis and anti-angiogenesis therapy |
| 02/23/2006 | WO2004011060A3 Delivery of molecules and complexes to mammalian cells in vivo |
| 02/23/2006 | WO2004001061A3 Antisense modulation of heme oxygenase 1 expression |
| 02/23/2006 | US20060041107 Mutants of streptococcal toxin A and methods of use |
| 02/23/2006 | US20060041105 Peptides whose uptake by cells is controllable |
| 02/23/2006 | US20060041023 Facially amphilic polymers and oligomers and uses thereof |
| 02/23/2006 | US20060041015 Administering treosulfan, busulfan, dimethyl busulfan, pentasulfan or hepsulfam, optionally immunomodulatory interferon- and/or glatriamer acetate; for treatment of relapsing-remitting, primary progressive and in particular secondary progressive MS |
| 02/23/2006 | US20060040893 Immunomodulatory methods using oligosaccharides |
| 02/23/2006 | US20060040880 Methods and compositions for treating neuropathic pain |
| 02/23/2006 | US20060040872 Calcium channel inhibitor |
| 02/23/2006 | US20060040871 Bacterial transforming agent |
| 02/23/2006 | US20060040870 Enhancement of apoptosis by caspase-9 inhibitors |
| 02/23/2006 | US20060040869 Pharmaceutically useful compounds |
| 02/23/2006 | US20060040868 Methods for treating premature infants |
| 02/23/2006 | US20060040867 Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections |
| 02/23/2006 | US20060040866 Peptides and compounds that bind to a receptor |
| 02/23/2006 | US20060040865 Platelet production promoting agent |
| 02/23/2006 | US20060040864 Apparatus and method for transdermal delivery of vascular endothelial growth factors |
| 02/23/2006 | US20060040863 Methods for treatment of diabetes using peptide analogues of insulin |
| 02/23/2006 | US20060040862 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
| 02/23/2006 | US20060040861 Method of treating, preventing, and diagnosing prostate cancer |
| 02/23/2006 | US20060040860 Intra-tracheal application of vascular endothelial growth factor (VEGF) for the prevention of lung damages caused by hperoxia |
| 02/23/2006 | US20060040859 Peptides, DNAs, RNAs, and compounds for inhibiting or inducing adrenomedullin activity, and use of the same |
| 02/23/2006 | US20060040858 Novel peptides that bind to the erythropoietin receptor |
| 02/23/2006 | US20060040857 1-Desamino-8-a-arginyl vasopressin analogs |
| 02/23/2006 | US20060040856 Complex of factor ix and polyoxyethylene glycol; stimulant of blood coagulation; blood diosrders |